Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis

<p>Abstract</p> <p>Background</p> <p>Evidence is accumulating that chronic inflammation may have an important role in prostate cancer (PCa). The COX-2 polymorphism rs2745557 (+202 C/T) has been extensively investigated as a potential risk factor for PCa, but the results...

Full description

Bibliographic Details
Main Authors: Zhang Hongtuan, Xu Yong, Zhang Zhihong, Liu Ranlu, Ma Baojie
Format: Article
Language:English
Published: BMC 2012-03-01
Series:BMC Immunology
Online Access:http://www.biomedcentral.com/1471-2172/13/14
_version_ 1818058865205313536
author Zhang Hongtuan
Xu Yong
Zhang Zhihong
Liu Ranlu
Ma Baojie
author_facet Zhang Hongtuan
Xu Yong
Zhang Zhihong
Liu Ranlu
Ma Baojie
author_sort Zhang Hongtuan
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Evidence is accumulating that chronic inflammation may have an important role in prostate cancer (PCa). The COX-2 polymorphism rs2745557 (+202 C/T) has been extensively investigated as a potential risk factor for PCa, but the results have thus far been inconclusive. This meta-analysis was performed to derive a more precise estimation of the association.</p> <p>Methods</p> <p>A comprehensive search was conducted to identify all case-control studies of COX-2 rs2745557 polymorphism and PCa risk. We used odds ratios (ORs) to assess the strength of the association, and 95% confidence intervals (CIs) give a sense of the precision of the estimate. Statistical analyses were performed by Review Manage, version 5.0 and Stata 10.0.</p> <p>Results</p> <p>A total of 8 available studies were considered in the present meta-analysis, with 11356 patients and 11641 controls for rs2745557. When all groups were pooled, there was no evidence that rs2745557 had significant association with PCa under co-dominant, recessive, over-dominant, and allelic models. However, our analysis suggested that rs2745557 was associated with a lower PCa risk under dominant model in overall population (OR = 0.85, 95%CI = 0.74-0.97, P = 0.02). When stratifying for race, there was a significant association between rs2745557 polymorphism and lower PCa risk in dominant model comparison in the subgroup of Caucasians (OR = 0.86, 95%CI = 0.75-0.99, P = 0.04), but not in co-dominant, recessive, over-dominant and allelic comparisons.</p> <p>Conclusion</p> <p>Based on our meta-analysis, COX-2 rs2745557 was associated with a lower PCa risk under dominant model in Caucasians.</p>
first_indexed 2024-12-10T13:07:25Z
format Article
id doaj.art-d224ef09664546bc9711ab7faf2a430d
institution Directory Open Access Journal
issn 1471-2172
language English
last_indexed 2024-12-10T13:07:25Z
publishDate 2012-03-01
publisher BMC
record_format Article
series BMC Immunology
spelling doaj.art-d224ef09664546bc9711ab7faf2a430d2022-12-22T01:47:48ZengBMCBMC Immunology1471-21722012-03-011311410.1186/1471-2172-13-14Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysisZhang HongtuanXu YongZhang ZhihongLiu RanluMa Baojie<p>Abstract</p> <p>Background</p> <p>Evidence is accumulating that chronic inflammation may have an important role in prostate cancer (PCa). The COX-2 polymorphism rs2745557 (+202 C/T) has been extensively investigated as a potential risk factor for PCa, but the results have thus far been inconclusive. This meta-analysis was performed to derive a more precise estimation of the association.</p> <p>Methods</p> <p>A comprehensive search was conducted to identify all case-control studies of COX-2 rs2745557 polymorphism and PCa risk. We used odds ratios (ORs) to assess the strength of the association, and 95% confidence intervals (CIs) give a sense of the precision of the estimate. Statistical analyses were performed by Review Manage, version 5.0 and Stata 10.0.</p> <p>Results</p> <p>A total of 8 available studies were considered in the present meta-analysis, with 11356 patients and 11641 controls for rs2745557. When all groups were pooled, there was no evidence that rs2745557 had significant association with PCa under co-dominant, recessive, over-dominant, and allelic models. However, our analysis suggested that rs2745557 was associated with a lower PCa risk under dominant model in overall population (OR = 0.85, 95%CI = 0.74-0.97, P = 0.02). When stratifying for race, there was a significant association between rs2745557 polymorphism and lower PCa risk in dominant model comparison in the subgroup of Caucasians (OR = 0.86, 95%CI = 0.75-0.99, P = 0.04), but not in co-dominant, recessive, over-dominant and allelic comparisons.</p> <p>Conclusion</p> <p>Based on our meta-analysis, COX-2 rs2745557 was associated with a lower PCa risk under dominant model in Caucasians.</p>http://www.biomedcentral.com/1471-2172/13/14
spellingShingle Zhang Hongtuan
Xu Yong
Zhang Zhihong
Liu Ranlu
Ma Baojie
Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis
BMC Immunology
title Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis
title_full Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis
title_fullStr Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis
title_full_unstemmed Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis
title_short Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis
title_sort association between cox 2 rs2745557 polymorphism and prostate cancer risk a systematic review and meta analysis
url http://www.biomedcentral.com/1471-2172/13/14
work_keys_str_mv AT zhanghongtuan associationbetweencox2rs2745557polymorphismandprostatecancerriskasystematicreviewandmetaanalysis
AT xuyong associationbetweencox2rs2745557polymorphismandprostatecancerriskasystematicreviewandmetaanalysis
AT zhangzhihong associationbetweencox2rs2745557polymorphismandprostatecancerriskasystematicreviewandmetaanalysis
AT liuranlu associationbetweencox2rs2745557polymorphismandprostatecancerriskasystematicreviewandmetaanalysis
AT mabaojie associationbetweencox2rs2745557polymorphismandprostatecancerriskasystematicreviewandmetaanalysis